Interventions to improve access to opioid agonist therapy in acute hospitals: A scoping review
Open Access
- 30 May 2025
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Mental Health
- Vol. 2 (5) , e0000322
Abstract
Many people who use illicit opioids have negative experiences when admitted to hospital, which is partly due to poor availability of opioid agonist therapy (OAT). We conducted a scoping review of interventions to increase access OAT to for hospital patients, with searches of MEDLINE, EMBASE, PsychINFO, and CINAHL for evaluations published before 29 July 2024. We followed a registered protocol (identifier: CRD42022313237). We included interventions in acute inpatient or emergency department settings, and extracted intervention characteristics, location, evaluation design and quality, and evidence for effectiveness. We included 57 studies; 50 from the United States, six from Canada, and one from the UK. Fifty-one were published in 2015 or later. We identified three intervention classes: (a) pathways to initiate OAT in emergency departments, entailing screening patients or training staff to identify withdrawal, initiating buprenorphine, and supported referrals (26 studies); (b) multidisciplinary ‘addiction consult teams’, which provide substance-related care across hospital departments, advise primary medical teams on issues such as pain relief and withdrawal management, and support patients with discharge and onward care (18 studies); and (c) Interventions that build capacity of general clinical teams to provide OAT to inpatients, including protocols to identify patients who need OAT, multidisciplinary patient review, and training/clinical education (13 studies). Most interventions included multiple components, and the most common were clinical education and measures to improve continuity of OAT after discharge, such as bridge prescriptions and supported referrals to community prescribers. Almost all studies concluded that interventions were effective, however evaluation methods were generally weak and most used before/after or case series designs. Efforts to improve OAT in acute hospitals emerged recently in North America and focus on addiction consult teams and initiation of buprenorphine in emergency departments. Although formal evaluation is weak, these models may represent starting points for national policy and larger research programmes.Keywords
Funding Information
- Health and Social Care Delivery Research Programme (NIHR133022)
- Canadian Institutes of Health Research (CIHR-FRN# 171259)
- National Institute on Drug Abuse (R25DA033211)
- Canadian Institutes of Health Research (CIHR-PCS# 185469)
- Medical Research Council (MR/W006308/1)
- Medical Research Council (MR/X018636/1)
This publication has 104 references indexed in Scilit:
- Caring for Hospitalized Adults With Opioid Use Disorder in the Era of FentanylJAMA Internal Medicine, 2024
- Hospital‐based opioid treatment: Expanding and sustaining the model in TexasJournal of Hospital Medicine, 2023
- Trends in Opioid Toxicity–Related Deaths in the US Before and After the Start of the COVID-19 Pandemic, 2011-2021JAMA Network Open, 2023
- Management of opioid use disorder, opioid withdrawal, and opioid overdose prevention in hospitalized adults: A systematic review of existing guidelinesJournal of Hospital Medicine, 2022
- Implementation of a comprehensive hospitalist‐led initiative to improve care for patients with opioid use disorderJournal of Hospital Medicine, 2022
- The Development and Implementation of a Hospitalist-Directed Addiction Medicine Consultation Service to Address a Treatment GapJournal of General Internal Medicine, 2021
- Spreading Addictions Care Across Oregon’s Rural and Community Hospitals: Mixed-Methods Evaluation of an Interprofessional Telementoring ECHO ProgramJournal of General Internal Medicine, 2020
- Inpatient Addiction Medicine Consultation and Post-Hospital Substance Use Disorder Treatment Engagement: a Propensity-Matched AnalysisJournal of General Internal Medicine, 2019
- Emergency Department–Initiated Buprenorphine/Naloxone Treatment for Opioid DependenceJAMA, 2015
- Buprenorphine Treatment for Hospitalized, Opioid-Dependent PatientsJAMA Internal Medicine, 2014